首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1163784篇
  免费   73689篇
  国内免费   1357篇
耳鼻咽喉   15712篇
儿科学   37481篇
妇产科学   30020篇
基础医学   164592篇
口腔科学   30020篇
临床医学   100260篇
内科学   221631篇
皮肤病学   24871篇
神经病学   90603篇
特种医学   47163篇
外国民族医学   201篇
外科学   178790篇
综合类   22519篇
现状与发展   1篇
一般理论   263篇
预防医学   82735篇
眼科学   25341篇
药学   91112篇
  7篇
中国医学   2791篇
肿瘤学   72717篇
  2019年   7791篇
  2018年   22004篇
  2017年   17624篇
  2016年   20485篇
  2015年   11688篇
  2014年   15609篇
  2013年   22532篇
  2012年   33567篇
  2011年   41884篇
  2010年   26573篇
  2009年   23473篇
  2008年   39957篇
  2007年   44454篇
  2006年   33028篇
  2005年   33159篇
  2004年   32235篇
  2003年   32242篇
  2002年   29973篇
  2001年   60355篇
  2000年   62002篇
  1999年   51153篇
  1998年   12629篇
  1997年   11216篇
  1996年   10500篇
  1995年   10450篇
  1994年   9487篇
  1993年   8968篇
  1992年   37900篇
  1991年   36427篇
  1990年   35872篇
  1989年   34412篇
  1988年   30979篇
  1987年   30116篇
  1986年   28315篇
  1985年   26555篇
  1984年   19241篇
  1983年   16163篇
  1982年   8882篇
  1979年   17095篇
  1978年   11443篇
  1977年   10213篇
  1976年   8889篇
  1975年   10053篇
  1974年   11671篇
  1973年   11272篇
  1972年   10753篇
  1971年   10093篇
  1970年   9274篇
  1969年   8971篇
  1968年   7934篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
Quality of Life Research - The COVID-19 pandemic might add to the stressors experienced by people living with rheumatic diseases. This study aimed to examine rheumatic patients’ functional...  相似文献   
3.
Molnár  B.  Aroca  S.  Dobos  A.  Orbán  K.  Szabó  J.  Windisch  P.  Stähli  A.  Sculean  A. 《Clinical oral investigations》2022,26(12):7135-7142
Clinical Oral Investigations - To evaluate t he long-term outcomes following treatment of RT 1 multiple adjacent gingival recessions (MAGR) using the modified coronally advanced tunnel (MCAT) with...  相似文献   
4.
Coronavirus disease-19 (COVID-19) caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is now a pandemic threat. This virus is supposed to be spread by human to human transmission. Cellular angiotensin-converting enzyme 2 (ACE2) is the receptor of SARS-CoV-2 which is identical or similar in different species of animals such as pigs, ferrets, cats, orangutans, monkeys, and humans. Moreover, a recent study predicted that dogs might be secondary hosts during the evolution of SARS-CoV-2 from bat to human. Therefore, there is a possibility of spreading SARS-CoV-2 through domestic pets. There are now many reports of SARS-CoV-2 positive cases in dogs, cats, tigers, lion, and minks. Experimental data showed ferrets and cats are highly susceptible to SARS-CoV-2 as infected by virus inoculation and can transmit the virus directly or indirectly by droplets or airborne routes. Based on these natural infection reports and experimental data, whether the pets are responsible for SARS-CoV-2 spread to humans; needs to be deeply investigated. Humans showing clinical symptoms of respiratory infections have been undergoing for the COVID-19 diagnostic test but many infected people and few pets confirmed with SARS-CoV-2 remained asymptomatic. In this review, we summarize the natural cases of SARS-CoV-2 in animals with the latest researches conducted in this field. This review will be helpful to think insights of SARS-CoV-2 transmissions, spread, and demand for seroprevalence studies, especially in companion animals.  相似文献   
5.
6.
7.
8.
9.
Inflammatory bowel disease (IBD) is a chronic disease that requires chronic treatment throughout the evolution of the disease, with a complex physiopathology that entails great challenges for the development of new and specific treatments for ulcerative colitis and Crohn´s disease. The anti-tumor necrosis factor alpha therapy has impacted the clinical course of IBD in those patients who do not respond to conventional treatment, so there is a need to develop new therapies and markers of treatment response. Various pathways involved in the development of the disease are known and the new therapies have focused on blocking the inflammatory process at the gastrointestinal level by oral, intravenous, subcutaneous, and topical route. All these new therapies can lead to more personalized treatments with higher success rates and fewer relapses. These treatments have not only focused on clinical remission, but also on achieving macroscopic changes at the endoscopic level and microscopic changes by achieving mucosal healing. These treatments are mainly based on modifying signaling pathways, by blocking receptors or ligands, reducing cell migration and maintaining the integrity of the epithelial barrier. Therefore, this review presents the efficacy and safety of the new treatments that are currently under study and the advances that have been made in this area in recent years.  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号